Efficacy of bazedoxifene for the prevention of postmenopausal osteoporosis: Results of a 2-year, phase III, placebo- and active-controlled study

被引：0
|
作者：
Kendler, D. L. [1 ]
Miller, P. D. [2 ]
Christiansen, C. [3 ]
Hoeck, H. C. [3 ]
Adachi, J. D. [4 ]
Lewiecki, E. M. [5 ]
Woodson, G. [6 ]
Ciesielska, M. [7 ]
Chines, A. A. [7 ]
Constantine, G. [7 ]
Delmas, P. D. [8 ,9 ]
机构：
[1] Osteoporosis Res Ctr, Vancouver, BC, Canada
[2] Univ Colorado, Med Ctr, Denver, CO 80202 USA
[3] Ctr Clin & Basic Res, Ballerup, Denmark
[4] McMaster Univ, St Josephs Hosp, Hamilton, ON, Canada
[5] New Mexico Clin Res & Osteoporosis Ctr Inc, Albuquerque, NM USA
[6] Atlanta Res Ctr, Decatur, GA USA
[7] Wyeth Pharmaceut, Collegeville, PA USA
[8] Univ Lyon, Lyon, France
[9] INSERM, Res Unit 831, Lyon, France
来源：
JOURNAL OF RHEUMATOLOGY | 2008年 / 35卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1189 / 1189
页数：1
相关论文
共 50 条
  • [31] POSITIVE RESULTS WITH ITI-007 FOR THE TREATMENT OF SCHIZOPHRENIA: A RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED PHASE 2 STUDY
    Vanover, Kimberly
    Davis, Robert E.
    Ereshefsky, Larry
    Mates, Sharon
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S278 - S279
  • [32] A Randomized, Placebo- and Active-Controlled Phase 2b Study Investigating Oliceridine (TRV130)
    Soergel, David
    Minkowitz, Harold
    Burt, David
    Skobieranda, Franck
    PAIN MANAGEMENT NURSING, 2017, 18 (02) : 71 - 72
  • [33] BAZEDOXIFENE/CONJUGATED ESTROGENS: EFFECTS ON BONE MINERAL DENSITY AND BONE TURNOVER MARKERS IN A DOUBLE-BLIND, RANDOMIZED, PLACEBO- AND ACTIVE-CONTROLLED PHASE 3 STUDY
    Gallagher, J. Christopher
    Lindsay, Robert
    Pan, Kaijie
    Ryan, Kelly A.
    Mirkin, Sebastian
    Chines, Arkadi A.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S63 - S64
  • [34] Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety
    Markman, John D.
    Bolash, Robert B.
    McAlindon, Timothy E.
    Kivitz, Alan J.
    Pombo-Suarez, Manuel
    Ohtori, Seiji
    Roemer, Frank W.
    Li, David J.
    Viktrup, Lars
    Bramson, Candace
    West, Christine R.
    Verburg, Kenneth M.
    PAIN, 2020, 161 (09) : 2068 - 2078
  • [35] Efficacy and Tolerability of Intravenous Ibandronate Injections in Postmenopausal Osteoporosis: 2-Year Results from the DIVA Study
    Mikosch, P.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2008, 15 (03): : 159 - +
  • [36] Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study
    Eisman, John A.
    Civitelli, Roberto
    Adaml, Silvano
    Czerwinski, Edward
    Recknor, Chris
    Prince, Richard
    Reginster, Jean-Yves
    Zaidi, Mone
    Felsenberg, Dieter
    Hughes, Claire
    Mairon, Nicole
    Masanauskaite, Daiva
    Reid, David M.
    Delmas, Pierre D.
    Recker, Robert R.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (03) : 488 - 497
  • [37] A randomised, phase 2, placebo- and active-controlled dose-ranging study of semaglutide for treatment of obesity in subjects without diabetes
    Wilding, J.
    Birkenfeld, A. L.
    McGowan, B.
    Mosenzon, O.
    Pedersen, S. D.
    Wharton, S.
    Kabisch, M.
    Carson, C. G.
    O'Neil, P. M.
    DIABETOLOGIA, 2018, 61 : S273 - S274
  • [38] A Randomized Alendronate-Controlled Trial of Romosozumab: Results of the Phase 3 Active-Controlled Fracture Study in Postmenopausal Women with Osteoporosis at High Risk
    Saag, Kenneth
    Petersen, Jeffrey
    Brandi, Maria Luisa
    Karaplis, Andrew
    Lorentzon, Mattias
    Thomas, Thierry
    Maddox, Judy
    Fan, Michelle
    Meisner, Paul D.
    Grauer, Andreas
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [39] Efficacy of Cariprazine Across Schizophrenia Symptoms: A Post Hoc Analysis of PANSS Data from a Phase III, Double-blind, Placebo- and Active-controlled Trial
    Zukin, Stephen R.
    Lieberman, Jeffrey A.
    Cutler, Andrew J.
    Lu, Kaifeng
    Migliore, Raffaele
    Laszlovszky, Istvan
    Nemeth, Gyoergy
    Durgam, Suresh
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S379 - S380
  • [40] Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: Results of a 7-year, randomized, placebo-controlled, phase 3 study
    Palacios, Santiago
    de Villiers, Tobie J.
    Nardone, Fiorenzo de Cicco
    Levine, Amy B.
    Williams, Robert
    Hines, Teresa
    Mirkin, Sebastian
    Chines, Arkadi A.
    MATURITAS, 2013, 76 (01) : 81 - 87
12345